Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma-Reference-Cited by-同舟云学术

Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma

Published:2015-08 Issue:2 Volume:158 Page:331-338
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Ady Justin W.,Johnsen Clark,Mojica Kelly,Heffner Jacqueline,Love Damon,Pugalenthi Amudhan,Belin Laurence J.,Chen Nanhai G.,Yu Yong A.,Szalay Aladar A.,Fong Yuman

Publisher

Elsevier BV

Subject

Surgery

Reference17 articles.

1. Hepatocellular carcinoma from an immunologic perspective;Greten;Clin Cancer Res,2013

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. Systemic therapies in hepatocellular carcinoma;Worns;Dig Dis,2009

5. Oncolytic vaccinia virus for the treatment of cancer;Guse;Expert Opin Biol Ther,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy;Vaccine: X;2024-08

2. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

3. Gene Therapy Cargoes Based on Viral Vector Delivery;Current Gene Therapy;2023-04

4. Oncolytic virus-based hepatocellular carcinoma treatment: Current status, intravenous delivery strategies, and emerging combination therapeutic solutions;Asian Journal of Pharmaceutical Sciences;2023-01

5. Application of Viruses for Gene Therapy and Vaccine Development;The Biological Role of a Virus;2022